How can we improve patient care in hidradenitis suppurativa?

Authors

Institutions

Publication Details

Journal
Journal of the European Academy of Dermatology and Venereology
Published
2026-01-27
DOI
https://doi.org/10.1111/jdv.70259
Primary Topic
Hidradenitis Suppurativa and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

How can we improve patient care in hidradenitis suppurativa?

Sabine Kruger‐Krasagakis, Konstantinos Krasagakis, Maria Polina Konstantinou
Journal of the European Academy of Dermatology and Venereology
Hidradenitis Suppurativa and Treatments
article

How can we improve patient care in hidradenitis suppurativa?

Sabine Kruger‐Krasagakis, Konstantinos Krasagakis, Maria Polina Konstantinou
article en

Abstract

No abstract available for this paper.
Journal of the European Academy of Dermatology and VenereologyVol. 40(2)
University of Crete (GR), University Hospital of Heraklion (GR)
Eli Lilly and Company, Pfizer, Sanofi, Galderma, LEO Pharma
Openalex Percentile: Top 77%
Hidradenitis Suppurativa and Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

How can we improve patient care in hidradenitis suppurativa? — Sabine Kruger‐Krasagakis, Konstantinos Krasagakis, et al. · Journal of the European Academy of Dermatology and Venereology (2026) | TGRS Research Map | TGRS